Pharmafile Logo
Pharmafocus logo
Advanced Search

Eisai to appeal against Alzheimer’s court ruling

October 3, 2007
Alzheimer's, Eisai, NICE

Eisai and Pfizer are to try once again to reverse NICE restrictions on Alzheimer’s drugs by appealing against the recent …

News

FDA rejects painkiller Prexige

October 3, 2007
Sales and Marketing reg, safety

Novartis has received a "not approvable" letter from the FDA for its painkiller Prexige because of concerns about potential liver …

News

Roche cuts Tarceva price while NICE deliberate

October 3, 2007

Roche has announced that it is to cut the price of its lung cancer treatment Tarceva for a limited time …

News

Latest news from Datamonitor

October 1, 2007
Research and Development

Cubicin approved for marketing in CanadaCubist Pharmaceuticals has said that Health Canada has approved Cubicin for marketing in Canada, where …

News

Finding top people for the top job

October 1, 2007
Business Services careers, management, recruitment

When it comes to filling the most senior roles in a company, whatever its size, executive search is, more often …

Feature

Leukaemia drug enters phase III studies in MS

September 28, 2007
Research and Development

Patients with multiple sclerosis could benefit from a drug currently used to treat leukaemia, with late-stage trials now commencing.Discovered by …

News

Society launches MS awareness campaign

September 28, 2007
Medical Communications

The MS Society has launched a campaign to raise awareness of multiple sclerosis and the help the patient group can …

News

Regulators and pharma to join forces on drug safety monitoring

September 28, 2007
Sales and Marketing reg, safety

Regulators, the pharma industry and academic institutions are to come together in a new global alliance to research drug side-effects. …

News

mXm launches event ROI Monitor

September 28, 2007
Medical Communications

mXm Medical Communications has launched a new tool to measure the return on investment from communications activities at medical meetings.Its …

News

BMA resists plans for London polyclinics

September 28, 2007

Recent government proposals to centralise London healthcare have met resistance among GPs. Independent trade union for doctors, the British Medical …

News

BMS makes $430m biotech acquisition

September 27, 2007
Research and Development

Bristol-Myers Squibb has significantly advanced its strategy to move into biologics with the acquisition of US biotech Adnexus.The $430 million …

News

News roundup from Datamonitor

September 26, 2007
Sales and Marketing

Alnylam and Merck end collaborationBiopharmaceutical company Alnylam Pharmaceuticals and Merck & Co. have mutually agreed to terminate their July 2006 …

News

UK clinical trials: on the mend?

September 26, 2007
Research and Development UK, clinical trials, global, research

How clinical research is organised in the UK is essential to the success of Britain's pharma industry, and to the …

Feature

Global products for local people: tailoring your brand strategy

September 25, 2007
Medical Communications, Sales and Marketing branding, global

Deciding which aspects of a global brand should be defined centrally and how much freedom there is in any given …

Feature

European approval for GSK’s cancer vaccine

September 25, 2007
Sales and Marketing

GlaxoSmithKline's cervical cancer vaccine Cervarix has been approved in Europe, setting it up for a head-to-head clash with Sanofi-Pasteur MSD's …

News

Pfizer’s Celsentri approved in Europe

September 25, 2007
Research and Development, Sales and Marketing HIV

Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …

News

Brown outlines plans for NHS in a ‘new era’

September 25, 2007

The Prime Minister has outlined his plans to provide NHS patients with a more personalised service fit for the 21st …

News

AstraZeneca denies outsourcing plans

September 25, 2007
Manufacturing and Production

AstraZeneca has denied it plans to outsource its drug manufacturing requirements by 2017, following comments made by a senior board …

News

Takeda claims safety advantages for Actos

September 20, 2007
Sales and Marketing

Takeda says new data on its diabetes drug Actos shows a number of safety advantages over GSK's rival product Avandia.Two …

News

Clinton unveils plans for universal healthcare

September 19, 2007
Sales and Marketing

Hilary Clinton has unveiled plans to introduce universal healthcare insurance in America as part of her campaign to become US …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025